Varadha Balaji Venkadakrishnan

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Topics

Dna Methylation

Radical Prostatectomy

Long Noncoding Rna

Top Venues

Research square

Nature communications

Cancer research

Endocrine-related cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Varadha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, Matthew A Booker, Nicole A Traphagen, Kenny Weng, Nathaniel C E Voss, Navin R Mahadevan, Kei Mizuno, Loredana Puca, Osasenaga Idahor, Sheng Yu Ku, Martin K Bakht, Ashir A Borah, Zachary T Herbert, Michael Yevgeniy Tolstorukov, David A Barbie, David S Rickman, Myles A Brown, Himisha Beltran
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes. Nature communications 15 (1) (2024)
Varadha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, Matthew A Booker, Nicole A Traphagen, Kenny Weng, Nathaniel C Voss, Navin R Mahadevan, Kei Mizuno, Loredana Puca, Osasenaga Idahor, Sheng Yu Ku, Martin K Bakht, Ashir A Borah, Zachary T Herbert, Michael Y Tolstorukov, David A Barbie, David S Rickman, Myles A Brown, Himisha Beltran
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes. Research square (2024)
Varadha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, Matthew A Booker, Nicole A Traphagen, Kenny Weng, Nathaniel C E Voss, Navin R Mahadevan, Kei Mizuno, Loredana Puca, Osasenaga Idahor, Sheng Yu Ku, Martin K Bakht, Ashir A Borah, Zachary T Herbert, Michael Yevgeniy Tolstorukov, David A Barbie, David S Rickman, Myles A Brown, Himisha Beltran
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes. Nature communications 15 (1) (2024)
Varadha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, Matthew A Booker, Nicole A Traphagen, Kenny Weng, Nathaniel C Voss, Navin R Mahadevan, Kei Mizuno, Loredana Puca, Osasenaga Idahor, Sheng Yu Ku, Martin K Bakht, Ashir A Borah, Zachary T Herbert, Michael Y Tolstorukov, David A Barbie, David S Rickman, Myles A Brown, Himisha Beltran
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes. Research square (2024)
Varadha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, Matthew A Booker, Nicole A Traphagen, Kenny Weng, Nathaniel C Voss, Navin R Mahadevan, Kei Mizuno, Loredana Puca, Osasenaga Idahor, Sheng Yu Ku, Martin K Bakht, Ashir A Borah, Zachary T Herbert, Michael Y Tolstorukov, David A Barbie, David S Rickman, Myles A Brown, Himisha Beltran
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes. Research square (2024)
Varadha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, Matthew A Booker, Nicole A Traphagen, Kenny Weng, Nathaniel C Voss, Navin R Mahadevan, Kei Mizuno, Loredana Puca, Osasenaga Idahor, Sheng-Yu Ku, Martin K Bakht, Ashir A Borah, Zachary T Herbert, Michael Y Tolstorukov, David A Barbie, David S Rickman, Myles Brown, Himisha Beltran
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes. Research square (2024)
Varadha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, Matthew A Booker, Nicole A Traphagen, Kenny Weng, Nathaniel C Voss, Navin R Mahadevan, Kei Mizuno, Loredana Puca, Osasenaga Idahor, Sheng Yu Ku, Martin K Bakht, Ashir A Borah, Zachary T Herbert, Michael Y Tolstorukov, David A Barbie, David S Rickman, Myles A Brown, Himisha Beltran
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes. Research square (2024)
Varadha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, Matthew A Booker, Nicole A Traphagen, Kenny Weng, Nathaniel C Voss, Navin R Mahadevan, Kei Mizuno, Loredana Puca, Osasenaga Idahor, Sheng Yu Ku, Martin K Bakht, Ashir A Borah, Zachary T Herbert, Michael Y Tolstorukov, David A Barbie, David S Rickman, Myles A Brown, Himisha Beltran
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes. Research square (2024)
Varadha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, Matthew A Booker, Nicole A Traphagen, Kenny Weng, Nathaniel C E Voss, Navin R Mahadevan, Kei Mizuno, Loredana Puca, Osasenaga Idahor, Sheng Yu Ku, Martin K Bakht, Ashir A Borah, Zachary T Herbert, Michael Yevgeniy Tolstorukov, David A Barbie, David S Rickman, Myles A Brown, Himisha Beltran
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes. Nature communications 15 (1) (2024)
Varadha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, Matthew A Booker, Nicole A Traphagen, Kenny Weng, Nathaniel C E Voss, Navin R Mahadevan, Kei Mizuno, Loredana Puca, Osasenaga Idahor, Sheng Yu Ku, Martin K Bakht, Ashir A Borah, Zachary T Herbert, Michael Yevgeniy Tolstorukov, David A Barbie, David S Rickman, Myles A Brown, Himisha Beltran
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes. Nature communications 15 (1) (2024)
Chitra Rawat, Salma Ben-Salem, Nidhi Singh, Gaurav Chauhan, Anja Rabljenovic, Vishwa Vaghela, Varadha Balaji Venkadakrishnan, Jonathan D Macdonald, Ujjwal Ranjan Dahiya, Yara Ghanem, Salam P Bachour, Yixue Su, Adam D DePriest, Sanghee Lee, Michelle Muldong, Hyun Tae Kim, Sangeeta Kumari, Malyn May Valenzuela, Dingxiao Zhang, Qiang Hu, Eduardo Cortes Gomez, Scott M Dehm, Amina Zoubeidi, Christina A M Jamieson, Marlo Nicolas, Jesse K McKenney, Belinda B Willard, Eric E Klein, Cristina Magi-Galluzzi, Shaun R Stauffer, Song Liu, Hannelore V Heemers
Prostate cancer progression relies on the mitotic kinase citron kinase. Cancer research (2023)
Martin K Bakht, Yasutaka Yamada, Sheng Yu Ku, Varadha Balaji Venkadakrishnan, Joshua A Korsen, Teja M Kalidindi, Kei Mizuno, Shin Hye Ahn, Ji-Heui Seo, Maria Mica Garcia, Francesca Khani, Olivier Elemento, Henry W Long, Alain Chaglassian, Naga Vara Kishore Pillarsetty, Jason S Lewis, Matthew L Freedman, Anthony P Belanger, Quang-De Nguyen, Himisha Beltran
Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer. Nature cancer (2023)
Varadha Balaji Venkadakrishnan, Yasutaka Yamada, Kenny Weng, Osasenaga Idahor, Himisha Beltran
Significance of RB Loss in Unlocking Phenotypic Plasticity in Advanced Cancers. Molecular cancer research : MCR (2023)
Yasutaka Yamada, Varadha Balaji Venkadakrishnan, Kei Mizuno, Martin K Bakht, Sheng Yu Ku, Maria Mica Garcia, Himisha Beltran
Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer. Science translational medicine 15 (722) (2023)
Martin K Bakht, John J Hayward, Farsheed Shahbazi-Raz, Magdalena Skubal, Ryo Tamura, Keith F Stringer, Daniel Meister, Varadha Balaji Venkadakrishnan, Hui Xue, Adam Pillon, Mathew Stover, Adam Tronchin, Bre-Anne Fifield, Lavleen K Mader, Sheng-Yu Ku, Gi Jeong Cheon, Keon-Wook Kang, Yuzhuo Z Wang, Xuesen Dong, Himisha Beltran, Jan Grimm, Lisa A Porter, John F Trant
Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells. Proceedings of the National Academy of Sciences of the United States of America 119 (4) (2022)
Haoyan Li, Yin Wang, Kevin Lin, Varadha Balaji Venkadakrishnan, Martin K Bakht, Wei Shi, Chenling Meng, Jie Zhang, Kaitlyn Tremble, Xin Liang, Jian H Song, Xu Feng, Vivien Van, Pingna Deng, Jared K Burks, Ana M Aparicio, Khandan Keyomarsi, Junjie Chen, Yue Lu, Himisha Beltran, Di Zhao
CHD1 Promotes Sensitivity to Aurora Kinase Inhibitors by Suppressing Interaction of AURKA with Its Coactivator TPX2. Cancer research 82 (17) (2022)
Salma Ben-Salem, Varadha Balaji Venkadakrishnan, Hannelore V Heemers
Novel insights in cell cycle dysregulation during prostate cancer progression. Endocrine-related cancer 28 (6) (2021)
Salma Ben-Salem, Varadha Balaji Venkadakrishnan, Hannelore V Heemers
Genomic alterations impact cell cycle-related genes during prostate cancer progression. Endocrine-related cancer 28 (6) (2021)
Varadha Balaji Venkadakrishnan, Adam D DePriest, Sangeeta Kumari, Dhirodatta Senapati, Salma Ben-Salem, Yixue Su, Giridhar Mudduluru, Qiang Hu, Eduardo Cortes, Elena Pop, James L Mohler, Gissou Azabdaftari, Kristopher Attwood, Rajal B Shah, Christina Jamieson, Scott M Dehm, Cristina Magi-Galluzzi, Eric E Klein, Nima Sharifi, Song Liu, Hannelore V Heemers
Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy. Oncogene 38 (23) (2019)